Glenmark Pharmaceuticals Q1 FY27 Results: Revenue, Profit and Share Price Reaction
Glenmark Pharmaceuticals' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.
Revenue and net profit by quarter
Every quarter
| Quarter | Announced | Revenue | YoY | Net profit | YoY | Margin | EPS | Price reaction |
|---|---|---|---|---|---|---|---|---|
| Q1 FY27 | 31 Jul 2026, 7:52 pm IST | 4,018 | +23.1% | 483 | +930.3% | 12.0% | 17.11 | -0.2% |
| Q4 FY26 | 29 May 2026, 11:12 pm IST | 3,771 | +15.8% | -0.10 | -102.2% | -0.0% | 10.68 | -3.2% |
| Q3 FY26 | 30 Jan 2026, 8:23 pm IST | 3,901 | — | 403 | — | 10.3% | 14.29 | -4.7% |
| Q2 FY26 | 14 Nov 2025, 8:51 pm IST | 6,047 | — | 610 | — | 10.1% | 21.63 | -1.4% |
| Q1 FY26 | 14 Aug 2025, 6:43 pm IST | 3,264 | — | 46.87 | — | 1.4% | 1.66 | -3.5% |
| Q4 FY25 | 23 May 2025, 11:48 pm IST | 3,256 | — | 4.65 | — | 0.1% | 0.16 | -2.1% |
₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.
How GLENMARK shares react to results
Across the last 6 results here, the shares rose on 0 and fell on 6. The average move was -2.52%, and the average size of the move either way 2.52%; the biggest was -4.74% after the Q3 FY26 results. In the 1 quarters where profit grew year on year, the shares rose 0 times.
The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.
Questions
What were Glenmark Pharmaceuticals' Q1 FY27 results?
For the quarter to 30 Jun 2026, Glenmark Pharmaceuticals reported revenue of ₹4,018 crore (+23.1% year on year) and net profit of ₹483 crore (+930.3%), with basic EPS of ₹17.11.
How did Glenmark Pharmaceuticals shares react to the Q1 results?
They fell 0.17% on 3 Aug 2026, the first session that could trade on the results (announced after the close); that was 1.78 points worse than the Nifty 50 that day.
When is Glenmark Pharmaceuticals' next results date?
The board meets on 5 Nov 2026 to consider results, according to the company's intimation to NSE.
Do Glenmark Pharmaceuticals shares usually rise after results?
In the last 6 results here they rose 0 times and fell 6 times, moving 2.52% on average either way.
About this data
From Glenmark Pharmaceuticals' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See GLENMARK stock page for price, open interest and deals, all results declared this week and the results calendar, and GLENMARK dividend history.